Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cerebro NeuroTech
AddedApr 14, 2024
UpdatedJul 4, 2026
Cerebro NeuroTech

Cerebro NeuroTech

Pre-Seed

Cerebro is developing the world's most intelligent rapid detection software for Sports-Related Concussions

Overview
Compare
Fundraising
Website

Cerebro NeuroTech was founded with the mission to revolutionize concussion detection and diagnosis through advanced AI technology. The company's core product, Trinity, is a physiological and cognitive predictive AI digital human designed to rapidly detect concussions at the onset of injury. Focused primarily on the sports industry, Cerebro NeuroTech aims to provide accurate, real-time assessments to improve player safety and health outcomes.

Notable affiliates include experts in AI and neurology, contributing to the development of their cutting-edge software. The company has garnered attention from prominent investors and media outlets like Sports Business Journal and Miami Herald for its innovative approach. Cerebro NeuroTech's key achievements include significant advancements in concussion detection accuracy, positioning it as a leader in sports health technology and making a substantial impact on athlete safety.

Cerebro NeuroTech - Similar Companies

i-Brain Tech logo

i-Brain Tech

i-brain.tech

HealthTechApps logo

HealthTechApps

healthtechapps.com

neuroLytixs logo

neuroLytixs

neurolytixs.com

HitCheck logo

HitCheck

hitcheck.com

SportGait logo

SportGait

sportgait.com

CerebraAI logo

CerebraAI

cerebraai.ai

NeuroTrainer logo

NeuroTrainer

neurotrainer.com

Cerebro Sports logo

Cerebro Sports

cerebrosports.com

Neurosity logo

Neurosity

neurosity.co

Cerebri AI logo

Cerebri AI

cerebriai.com

neuroFit logo

neuroFit

neurofit.tech

Synaptek logo

Synaptek

Cortechs.ai logo

Cortechs.ai

cortechs.ai

NeuroReef logo

NeuroReef

neuroreef.com

Brain Sentry logo

Brain Sentry

Cerebro NeuroTech - Quick Facts

Who are Cerebro NeuroTech's competitors?

Companies similar to Cerebro NeuroTech include i-Brain Tech, HealthTechApps, neuroLytixs and HitCheck.

When was Cerebro NeuroTech's last funding round?

Cerebro NeuroTech's most recent funding round was for $20k (USD) in January 2022.

How much has Cerebro NeuroTech raised to-date?

As of Jan 1, 2022, Cerebro NeuroTech has raised a total of $20k (USD).

Cerebro NeuroTech - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • AI Software
Tags
  • Healthtech
  • Sports